-transparent.png){kind=logo}
Oral transmucosal fentanyl citrate (OTFC) is a novel, noninvasive dosage form of fentanyl used to provide children and adults with sedation, anxiolysis, and analgesia. In order to determine the bioavailability and absorption of fentanyl from OTFC, 12 volunteers were given intravenous fentanyl citrate or OTFC 15 micrograms/kg on each of two occasions. On a third occasion, the authors assessed oral administration (gastrointestinal absorption) by giving eight of the same volunteers the same dose of a solution of fentanyl citrate to swallow. In each study, arterial blood samples were taken over 24 h for analysis of plasma fentanyl. After intravenous (iv) administration of fentanyl, clearance (mean +/- standard deviation) was 0.67 +/- 0.15 l/min; volume of distribution at steady state was 287 +/- 79 l; and the terminal elimination half-life was 425 +/- 102 min. Peak plasma concentrations of fentanyl were higher (3.0 +/- 1.0 vs. 1.6 +/- 0.6 ng/ml, P = 0.01) and occurred sooner (22 +/- 2.5 vs. 101 +/- 48.8 min, P = 0.003) after OTFC than after oral solution administration. Plasma concentrations of fentanyl after OTFC decreased rapidly, to less than 1.0 ng/ml within 75-135 min after the beginning of administration. Peak absorption rate was greater (11.1 +/- 4.3 vs. 3.6 +/- 2.1 micrograms/min, P = 0.004) and occurred much sooner after OTFC than after oral solution administration (19 +/- 2.6 vs. 87.5 +/- 38.1 min, P = 0.001). Systemic bioavailability was greater after OTFC administration than after the oral solution (0.52 +/- 0.1 vs. 0.32 +/- 0.1, P = 0.01).(ABSTRACT TRUNCATED AT 250 WORDS)
J B Streisand, and
J R Varvel, and
D R Stanski, and
L Le Maire, and
M A Ashburn, and
B I Hague, and
S D Tarver, and
T H Stanley
March 1994,
The Medical letter on drugs and therapeutics,
J B Streisand, and
J R Varvel, and
D R Stanski, and
L Le Maire, and
M A Ashburn, and
B I Hague, and
S D Tarver, and
T H Stanley
March 2007,
Journal of clinical pharmacology,
J B Streisand, and
J R Varvel, and
D R Stanski, and
L Le Maire, and
M A Ashburn, and
B I Hague, and
S D Tarver, and
T H Stanley
January 2013,
Drug delivery,
J B Streisand, and
J R Varvel, and
D R Stanski, and
L Le Maire, and
M A Ashburn, and
B I Hague, and
S D Tarver, and
T H Stanley
December 2005,
Journal of pain and symptom management,
J B Streisand, and
J R Varvel, and
D R Stanski, and
L Le Maire, and
M A Ashburn, and
B I Hague, and
S D Tarver, and
T H Stanley
July 1989,
Anesthesia and analgesia,
J B Streisand, and
J R Varvel, and
D R Stanski, and
L Le Maire, and
M A Ashburn, and
B I Hague, and
S D Tarver, and
T H Stanley
May 2008,
Journal of palliative medicine,
J B Streisand, and
J R Varvel, and
D R Stanski, and
L Le Maire, and
M A Ashburn, and
B I Hague, and
S D Tarver, and
T H Stanley
December 2000,
British journal of anaesthesia,
J B Streisand, and
J R Varvel, and
D R Stanski, and
L Le Maire, and
M A Ashburn, and
B I Hague, and
S D Tarver, and
T H Stanley
February 1998,
Anesthesiology,
J B Streisand, and
J R Varvel, and
D R Stanski, and
L Le Maire, and
M A Ashburn, and
B I Hague, and
S D Tarver, and
T H Stanley
January 1996,
Anesthesia and analgesia,
J B Streisand, and
J R Varvel, and
D R Stanski, and
L Le Maire, and
M A Ashburn, and
B I Hague, and
S D Tarver, and
T H Stanley
January 2006,
Drug delivery,
